Prescription drug · BLA
Humatrope (Somatropin) NDC 0002-8147
Kit · Intramuscular, Subcutaneous · Eli Lilly and Company
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0002-8147-01 | 00002814701 | 1 TRAY in 1 CARTON (0002-8147-01) / 1 KIT in 1 TRAY * 2.88 mL in 1 CARTRIDGE (0002-7554-01) * 2.88 mL in 1 SYRINGE (0002-7618-01)Marketed from Jan 27, 2006 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Humatrope
- Generic name (nonproprietary)
- somatropin
- Dosage form
- Kit
- Route
- Intramuscular, Subcutaneous
- Labeler
- Eli Lilly and CompanyNDC labeler code 0002
- Product type
- Prescription drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 019640
- Marketing start
- Marketing end
- Identifiers
- Product ID 0002-8147_32f865e2-68df-47bc-b392-21b696a9f845SPL ID 32f865e2-68df-47bc-b392-21b696a9f845SPL set ID a774e1ae-3997-49ee-8b0e-99a2b315d409RxCUI 582969, 582971, 582974, 582976, 729232, 729234
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N400002814701followed by a unit qualifier and the quantityPackage 00002-8147-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
HUMATROPE is a recombinant human growth hormone indicated for: Pediatric Patients: growth failure due to inadequate secretion of endogenous growth hormone (GH); short stature associated with Turner syndrome; Idiopathic Short Stature (ISS), height standard deviation score (SDS) <-2.25, and associated with growth rates unlikely to permit attainment of adult height in the normal range; short stature or growth failure in short stature homeobox-containing gene (SHOX) deficiency; short stature born small for gestational age (SGA) with no catch-up growth by 2 years to 4 years of age. ( 1.1 ) Adult Patients: replacement of endogenous GH in adults with GH deficiency. ( 1.2 ) 1.1 Pediatric Patients HU…
Excerpt only. Read the full label for complete information.
About NDC 0002-8147
- What is NDC 0002-8147?
- 0002-8147 is the product NDC for Humatrope (somatropin) kit, listed with the FDA by Eli Lilly and Company. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Humatrope (Somatropin).
- Who is the labeler?
- Eli Lilly and Company, NDC labeler code 0002. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Humatrope?
- 2 other product NDCs are listed under this name. See all Humatrope NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Humatrope products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Humatropesomatropin | — | KitIntramuscular, Subcutaneous | Eli Lilly and Company | 0002-8149 | 00002-8149-01 |
| Humatropesomatropin | — | KitIntramuscular, Subcutaneous | Eli Lilly and Company | 0002-8148 | 00002-8148-01 |
Other NDCs under BLA 019640
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Humatropesomatropin | — | KitIntramuscular, Subcutaneous | Eli Lilly and Company | 0002-8149 |
| Humatropesomatropin | — | KitIntramuscular, Subcutaneous | Eli Lilly and Company | 0002-8148 |